中国神经再生研究(英文版) ›› 2017, Vol. 12 ›› Issue (9): 1401-1404.doi: 10.4103/1673-5374.215246

• 综述:神经损伤修复保护与再生 • 上一篇    下一篇

臭味剂可以在黑色化神经元和皮肤细胞中引发修复过程

  

  • 收稿日期:2017-08-18 出版日期:2017-09-15 发布日期:2017-09-15

Odorants could elicit repair processes in melanized neuronal and skin cells

Barbara Pavan1, Alessandro Dalpiaz2   

  1. 1 Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy
    2 Department of Chemistry and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy
  • Received:2017-08-18 Online:2017-09-15 Published:2017-09-15
  • Contact: Barbara Pavan, Ph.D.,pvnbbr@unife.it.
  • Supported by:

    This work was supported by the University of Ferrara (F72I15000470005) in the frame of the project FAR2014.

摘要:

 

 

orcid:0000-0001-8942-9310(Barbara Pavan)

Abstract:

 

The expression of ectopic olfactory receptors (ORs) in melanized cells, such as the human brain nigrostri­atal dopaminergic neurons and skin melanocytes, is here pointed out. ORs are recognized to regulate skin melanogenesis, whereas OR expression in the dopaminergic neurons, characterized by accumulation of pigment neuromelanin, is downregulated in Parkinson’s disease. Furthermore, the correlation between the pigmentation process and the dopamine pathway through α-synuclein expression is also highlighted. Purposely, these ORs are suggested as therapeutic target for neurodegenerative diseases related to the pig­mentation disorders. Based on this evidence, a possible way of turning odorants into drugs, acting on three specific olfactory receptors, OR51E2, OR2AT4 and VN1R1, is thus introduced. Various odorous molecules are shown to interact with these ORs and their therapeutic potential against melanogenic and neurodegen­erative dysfunctions, including melanoma and Parkinson’s disease, is suggested. Finally, a direct functional link between olfactory and endocrine systems in human brain through VN1R1 is proposed, helping to counteract female susceptibility to Parkinson’s disease in quiescent life.

Key words: OR51E2, OR2AT4, VN1R1, melanoma, Parkinson’s disease, β-ionone, sandalore, hedione